MYC and Burkitt lymphoma: Since the development of BL and other lymphoid malignancies requires additional genetic or epigenetic aberrations that cooperate with deregulated c-MYC expression, we previously set out to identify such cooperating mutations in an unbiased genome-wide functional genetic screen in vivo [1].